Covalent Organic Framework-Based Solid Phase Microextraction Coating for Rapid Screening and Quantification of Drugs of Abuse and Artificial Sweeteners in Surface Waters
Analytical Chemistry · 22.09.2026 · 98 (37) · 27280-27292
DOI: 10.1021/acs.analchem.6c00227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 09.09.2026. Verfasst von Diana M Cárdenas-Soracá und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Waterloo, Waterloo, ONN2L 3G1, Canada. Hauptthemen laut MEDLINE: Solid Phase Microextraction, Water Pollutants, Chemical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Canada Research Chair (CRC) Programs, Industrial Research Chair (NSERC-IRC), Natural Sciences and Engineering Research Council of Canada (NSERC).
Abstract (Originalsprache)
Solid-phase microextraction (SPME) has emerged as a powerful tool used for extracting analytes from complex matrices, offering high sensitivity, automation potential, and high-throughput efficiency. Despite its advantages, its performance is often limited by the selectivity and physicochemical properties of conventional coatings. This study addresses the limitations of conventional SPME coatings for monitoring environmental contaminants by introducing a nitrogen-rich covalent organic framework (COF) as an SPME extraction phase/coating. The COF-based SPME coating was implemented in a coated-blade spray (CBS) device format and was used to develop a robust analytical workflow that combined ambient mass spectrometry ionization via CBS for rapid screening, followed by LC-MS/MS for confirmation and quantification. Statistical validation using a t test showed that only 3 of 43 analytes exhibited statistically significant differences in loss during the microdesorption step of the CBS-MS/MS screening. The results demonstrate that the COF-based SPME coating facilitates simultaneous extraction of analytes with varying polarities from river samples without altering the sample matrix. The final protocol achieved limits of quantification ranging from 0.025 to 5 ng mL–1. The method was successfully applied to river samples, quantifying the target analytes and demonstrating that LC separation remains essential for confirmation. This work highlighted the effectiveness of a COF-based SPME coating as a next-generation extraction phase that simplifies rapid ambient MS screening, followed by traditional LC-MS/MS for confirmation and quantification, all within a single coated SPME device.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Waterloo, Waterloo, ONN2L 3G1, Canada.
ORCID-Profile: Diana M Cárdenas-Soracá, Emir Nazdrajić, Janusz Pawliszyn
Förderung
- Canada Research Chair (CRC) Programs
- Industrial Research Chair (NSERC-IRC)
- Natural Sciences and Engineering Research Council of Canada (NSERC)
Zitieren
APA
Cárdenas-Soracá, D. M., Sinha Roy, K., Nazdrajić, E., & Pawliszyn, J. (2026). Covalent Organic Framework-Based Solid Phase Microextraction Coating for Rapid Screening and Quantification of Drugs of Abuse and Artificial Sweeteners in Surface Waters. Analytical Chemistry, 98(37), 27280-27292. https://doi.org/10.1021/acs.analchem.6c00227
Vancouver
Cárdenas-Soracá DM, Sinha Roy K, Nazdrajić E, Pawliszyn J. Covalent Organic Framework-Based Solid Phase Microextraction Coating for Rapid Screening and Quantification of Drugs of Abuse and Artificial Sweeteners in Surface Waters. Analytical Chemistry. 2026;98(37):27280-27292. doi:10.1021/acs.analchem.6c00227
BibTeX
@article{CrdenasSorac2026,
author = {Cárdenas-Soracá, Diana M and Sinha Roy, Kanchan and Nazdrajić, Emir and Pawliszyn, Janusz},
title = {Covalent Organic Framework-Based Solid Phase Microextraction Coating for Rapid Screening and Quantification of Drugs of Abuse and Artificial Sweeteners in Surface Waters},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {37},
pages = {27280--27292},
doi = {10.1021/acs.analchem.6c00227}
}
EUVIMED